Actionable Stock Market Trading Newswire. Built for Traders, by Traders.
All news is property of their respective owners.

Qiagen Launches CRISPR-Specific Products For Gene-Editing Experiments

Qiagen NV (NYSE:QGEN) has launched dedicated solutions specific to CRISPR technology used for editing genomes and modifying gene function. QiaPrep&Amp CRISPR…
byVandana Singh
June 22, 2021
1 minute read
Total
0
Shares
0
0
0
0
0
0
  • Qiagen NV (NYSE:QGEN) has launched dedicated solutions specific to CRISPR technology used for editing genomes and modifying gene function.
  • QiaPrep&Amp CRISPR Kit and Q-Primer Solutions expand Qiagen portfolio for CRISPR applications.
  • The solutions allow researchers to analyze edited genetic material with speed and efficiency to determine how their interventions have changed the function of the DNA sequence in question.
  • The new products add to the range of Qiagen products that could also be used for CRISPR research, such as the QIAGEN EndoFree Plasmid Kits and Plasmid Plus Kits.
  • Price Action: QGEN shares closed at $47.26 on Monday.
 
Total
0
Shares
Share 0
Tweet 0
Share 0
Share 0
Share 0
Share 0
Related Posts